Growth Hormone Axis
Growth-hormone secretagogues, GHRH analogues and IGF-1 variants for GH-axis research.
Growth-hormone secretagogues, GHRH analogues, and IGF-1 variants studied at the GH/IGF-1 axis. This collection covers compounds investigated in receptor-binding and pituitary-signalling research.
Showing 5 products
CJC-1295 (no DAC)
CJC-1295 without DAC (Mod GRF 1-29) is a short-acting GHRH analogue that binds the pituitary GHRH receptor (Gs/cAMP) on somatotrophs.
IGF-1 LR3
IGF-1 LR3 (Long R3 IGF-1) is a long-acting IGF-1 analogue with reduced affinity for IGF binding proteins that signals through the IGF-1 receptor.
Ipamorelin
Ipamorelin is a pentapeptide GHRP that binds the ghrelin receptor GHS-R1a without reported ACTH, cortisol or prolactin co-release in preclinical studies.
Sermorelin
Sermorelin (GRF 1-29) is a synthetic GHRH-analogue peptide that binds the GHRH receptor on pituitary somatotrophs.
Somatropin
Somatropin is recombinant 191-amino-acid human growth hormone (rHGH), the reference compound for growth hormone receptor and IGF-1 axis research.
Understanding GH-axis peptides
Ipamorelin binds the ghrelin receptor (GHS-R) and Sermorelin binds the GHRH receptor, both linked to growth-hormone release signalling. CJC-1295 is a modified GHRH analogue, Somatropin is recombinant growth hormone (191 amino acids), and IGF-1 LR3 is a modified IGF-1 analogue that acts at the IGF-1 receptor. Mechanism and receptor are documented per product.
Research applications
These peptides are studied in receptor-binding assays and models of GH-axis signalling. Half-life data is noted on each page.
Quality, documentation and dispatch
All products in this category are pharmaceutical-grade, supplied with quality documentation, and intended strictly for research use. Milo-Lab ships discreetly from Thailand with secure worldwide dispatch, tracked from door to door.
All products are supplied strictly for laboratory and research purposes and are not intended for human consumption.